Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹1,187 Cr
down ₹14.4 Cr vs Sep 2024
- Stocks held
- 41
- up 2 vs Sep 2024
- Top 10 weight
- 47.7%
- of the portfolio in its ten largest
- Cash & debt
- 1.5%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 23
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In October 2024 it disclosed 41 stocks worth ₹1,187 Cr, down ₹14.4 Cr from Sep 2024. Its largest positions were Sun Pharmaceutical Industries Limited (11.3%), Cipla Limited (5.9%), Ajanta Pharma Limited (5.4%); the ten largest together made up 47.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.5% of its equity. Cash and debt stood at 1.5%. Compared with Sep 2024 the fund entered 2 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
54%
Top-10 weight is higher than 54% of peers
Breadth
44%
Holds more stocks than 44% of peers
Cash
23%
Holds more cash than 23% of peers
Holdings in October 2024
Download CSVEvery line the fund disclosed, with the change against Sep 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 11.29%
- Δ weight
- down 0.50 pts
- Value
- ₹134 Cr
- Δ value
- down ₹7.6 Cr
- Status
- Trimmed
- Weight
- 5.89%
- Δ weight
- down 0.30 pts
- Value
- ₹69.9 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 5.38%
- Δ weight
- up 0.05 pts
- Value
- ₹63.9 Cr
- Δ value
- down ₹17 L
- Status
- Held
- Weight
- 4.67%
- Δ weight
- down 0.22 pts
- Value
- ₹55.5 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 3.70%
- Δ weight
- up 1.16 pts
- Value
- ₹44 Cr
- Δ value
- up ₹13.4 Cr
- Status
- Added
- Weight
- 3.57%
- Δ weight
- up 0.09 pts
- Value
- ₹42.4 Cr
- Δ value
- up ₹53 L
- Status
- Added
- Weight
- 3.55%
- Δ weight
- down 0.33 pts
- Value
- ₹42.1 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 3.34%
- Δ weight
- up 0.09 pts
- Value
- ₹39.6 Cr
- Δ value
- up ₹61 L
- Status
- Added
- Weight
- 3.26%
- Δ weight
- down 0.08 pts
- Value
- ₹38.7 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 3.07%
- Δ weight
- up 0.01 pts
- Value
- ₹36.4 Cr
- Δ value
- down ₹26 L
- Status
- Trimmed
- Weight
- 3.06%
- Δ weight
- up 0.36 pts
- Value
- ₹36.3 Cr
- Δ value
- up ₹3.9 Cr
- Status
- Added
- Weight
- 3.05%
- Δ weight
- up 0.02 pts
- Value
- ₹36.2 Cr
- Δ value
- down ₹20 L
- Status
- Trimmed
- Weight
- 2.94%
- Δ weight
- down 0.10 pts
- Value
- ₹34.9 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 2.89%
- Δ weight
- down 0.03 pts
- Value
- ₹34.3 Cr
- Δ value
- down ₹73 L
- Status
- Trimmed
- Weight
- 2.42%
- Δ weight
- up 0.50 pts
- Value
- ₹28.8 Cr
- Δ value
- up ₹5.6 Cr
- Status
- Added
- Weight
- 2.40%
- Δ weight
- up 0.19 pts
- Value
- ₹28.5 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 2.29%
- Δ weight
- down 0.25 pts
- Value
- ₹27.2 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 2.07%
- Δ weight
- down 0.07 pts
- Value
- ₹24.6 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 2.07%
- Δ weight
- down 0.11 pts
- Value
- ₹24.6 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 2.07%
- Δ weight
- down 0.02 pts
- Value
- ₹24.5 Cr
- Δ value
- down ₹52 L
- Status
- Trimmed
- Weight
- 1.83%
- Δ weight
- up 0.14 pts
- Value
- ₹21.8 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 1.69%
- Δ weight
- down 0.05 pts
- Value
- ₹20.1 Cr
- Δ value
- down ₹83 L
- Status
- Trimmed
- Weight
- 1.65%
- Δ weight
- up 0.43 pts
- Value
- ₹19.6 Cr
- Δ value
- up ₹4.9 Cr
- Status
- Added
- Weight
- 1.63%
- Δ weight
- down 0.18 pts
- Value
- ₹19.4 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Weight
- 1.60%
- Δ weight
- up 0.11 pts
- Value
- ₹19 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 1.53%
- Δ weight
- down 0.06 pts
- Value
- ₹18.1 Cr
- Δ value
- down ₹92 L
- Status
- Trimmed
- Weight
- 1.50%
- Δ weight
- up 0.19 pts
- Value
- ₹17.8 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 1.46%
- Δ weight
- down 0.02 pts
- Value
- ₹17.4 Cr
- Δ value
- down ₹49 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.42%
- Δ weight
- down 1.84 pts
- Value
- ₹16.8 Cr
- Δ value
- down ₹22.3 Cr
- Status
- Trimmed
- Weight
- 1.35%
- Δ weight
- up 0.06 pts
- Value
- ₹16 Cr
- Δ value
- up ₹50 L
- Status
- Added
- Weight
- 1.30%
- Δ weight
- down 0.04 pts
- Value
- ₹15.5 Cr
- Δ value
- down ₹69 L
- Status
- Trimmed
- Weight
- 1.26%
- Δ weight
- up 0.06 pts
- Value
- ₹15 Cr
- Δ value
- up ₹59 L
- Status
- Added
- Weight
- 1.15%
- Δ weight
- down 0.06 pts
- Value
- ₹13.6 Cr
- Δ value
- down ₹92 L
- Status
- Trimmed
- Weight
- 1.08%
- Δ weight
- up 0.08 pts
- Value
- ₹12.9 Cr
- Δ value
- up ₹80 L
- Status
- Added
- Weight
- 1.04%
- Δ weight
- down 0.20 pts
- Value
- ₹12.3 Cr
- Δ value
- down ₹2.6 Cr
- Status
- Trimmed
- Weight
- 1.03%
- Δ weight
- down 0.10 pts
- Value
- ₹12.2 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 0.99%
- Δ weight
- up 0.52 pts
- Value
- ₹11.7 Cr
- Δ value
- up ₹6.1 Cr
- Status
- Added
- Weight
- 0.96%
- Δ weight
- down 0.09 pts
- Value
- ₹11.4 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 0.85%
- Δ weight
- down 0.24 pts
- Value
- ₹10.1 Cr
- Δ value
- down ₹3 Cr
- Status
- Trimmed
- Weight
- 0.84%
- Δ weight
- up 0.12 pts
- Value
- ₹10 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 0.42%
- Δ weight
- up 0.42 pts
- Value
- ₹5 Cr
- Δ value
- up ₹5 Cr
- Status
- New
- Weight
- 0.30%
- Δ weight
- up 0.30 pts
- Value
- ₹3.5 Cr
- Δ value
- up ₹3.5 Cr
- Status
- New
- 364 DAYS T - BILLDebt
- Weight
- 0.11%
- Δ weight
- up <0.01 pts
- Value
- ₹1.3 Cr
- Δ value
- up ₹1 L
- Status
- Added
What changed, Sep 2024 to Oct 2024
New New positions (2)
- Jubilant Pharmova Limited0.4% · ₹5 Cr
- Global Health Limited0.3% · ₹3.5 Cr
Exited Exited (0)
None.
Added Biggest additions
- Gland Pharma Limitedup ₹13.4 Cr (+1.16% pts)
- Sanofi Consumer Healthcare India Limitedup ₹6.1 Cr (+0.52% pts)
- Emcure Pharmaceuticals Limitedup ₹5.6 Cr (+0.50% pts)
- WINDLAS BIOTEC LTD
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.7 pts), and fell most in Healthcare Equipment & Supplies (−0.3 pts) and Insurance (−0.2 pts).
- Pharmaceuticals & Biotechnology75.8% → 76.5%+0.7 pts
- Healthcare Equipment & Supplies1.1% → 0.9%−0.3 pts
- Insurance1.3% → 1.1%−0.2 pts
- Healthcare Services21.8% → 21.6%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2021 | Sep 2023 | Apr 2024 | Jul 2024 | Sep 2024 | Oct 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 82.0% | 75.7% | 76.4% | 76.0% | 75.8% | 76.5% |
| Healthcare Services | 14.3% | 20.9% | 21.4% | 21.2% | 21.8% | 21.6% |
| Insurance | — | 0.8% | 0.6% | 1.4% | 1.3% | 1.1% |
| Healthcare Equipment & Supplies | 1.6% | 1.5% | 1.1% | 1.0% | 1.1% | 0.9% |
Allocation in Oct 2024change vs Sep 2024
- Pharmaceuticals & Biotechnology (27)76.5%▲ 0.7 pts
- Healthcare Services (12)21.6%▼ 0.2 pts
- Insurance (1)1.1%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2024
1.5%
▼ 1.8 pts vs Sep 2024
- Cash alone
- 1.4%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.7% – 3.4%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.